BMJ23h
P114 Population pharmacokinetics and dosing optimization of cefepime in neonates
Objective Cefepime, a fourth-generation cephalosporin, is used in the treatment of severe nosocomial infections in neonates. Pharmacokinetics of cefepime was limited. Therefore, we aimed to study the ...
BMJ2d
Interventions in primary and community care to reduce urgent paediatric hospital admissions: systematic review
Background There has been a rise in urgent paediatric hospital admissions and interventions to address this are required. Objective To systemically review the literature describing community (or ...
BMJ4d
Medication errors in the homes of children with chronic conditions
Correspondence to Dr Kathleen E Walsh, Benedict Second Floor, UMass Medical Center, 55 North Lake Avenue, Worcester, MA 01655, USA; walshk02{at}ummhc.org Background Children with chronic conditions ...
BMJ8d
Potential benefits and harms of universal newborn pulse oximetry screening: response to the UK National Screening Committee public consultation
Correspondence to Professor Andrew K Ewer, Neonatal Unit, Birmingham Womens Hospital, Birmingham B15 2TG, UK; a.k.ewer{at}bham.ac.uk In May 2019, the National Screening Committee (NSC) announced a ...
BMJ9d
What causes attention deficit hyperactivity disorder?
Attention deficit hyperactivity disorder (ADHD) affects around 1–3% of children. There is a high level of comorbidity with developmental and learning problems as well as with a variety of psychiatric ...
BMJ10d
Brain abscess in children, a two-centre audit: outcomes and controversies
Correspondence to Dr Vianney Gilard, Department of Pediatric Neurosurgery, Necker Enfants Malades Hospital, APHP, Paris 5 University, Paris 75015, France; vianneygilard{at}hotmail.fr Objective The aim ...
BMJ17d
Vancomycin-associated acute kidney injury epidemiology in children: a systematic review
Correspondence to Dr Louise Oni, Department of Women’s and Children’s Health, University of Liverpool, Liverpool, UK; louise.oni{at}liverpool.ac.uk Introduction Vancomycin is a recognised cause of ...
BMJ17d
Effectiveness of paediatric asthma hubs: a clinical pilot study
Background Children and young people (CYP) with asthma in the UK are at higher risk of poor outcomes compared with other high-income European countries due to factors including poor access to ...
BMJ17d
Should next-generation sequencing be considered as a first-line genetic investigation for children with early developmental impairment?
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ17d
Complications of excess weight seen in two tier 3 paediatric weight management services: an observational study
Background Children and young people living with severe obesity experience a range of complications of excess weight (CEW); however the prevalence of complications is not well defined. We have ...
BMJ17d
Cascade testing effectively identifies undiagnosed sickle cell disease in The Gambia: a quality improvement project
Objective Sickle cell disease (SCD) has a high mortality during childhood in many low and middle-income countries (LMICs). Early diagnosis improves outcomes but newborn screening is not well ...
BMJ17d
Hospital-recorded chronic health conditions in children with and without Down syndrome in England: a national cohort of births from 2003 to 2019
Objective The objective is to describe age-specific cumulative incidence for hospital-recorded indicators of chronic health conditions (CHCs) in children with Down syndrome (DS) compared with children ...